A Mindfulness-based Stress Reduction Program for IBD
Not applicable · Testing Mindfulness based stress reduction and Active Control · 1 site · Nova Scotia Health Authority
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing Mindfulness based stress reduction (a behavioral program) and Active Control as a possible treatment. Condition(s) listed: Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis).
Participants are assigned to groups by chance (randomized).
It is open-label: participants know what they are receiving.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- 18 years of age or older
- having a known diagnosis of IBD that is mildly to moderately active
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 70 participants are expected to take part.
- Start date: 2027-09-01 (planned).
- Main results expected around 2028-02-01 (estimate from the record).
- 1 study site listed in Canada.
Main thing being measured
- Psychological distress (GAD7) (Visit 1 (2 months post enrollment))
In the researchers’ words
The gut-brain connection is important for good health and when it is disrupted it can worsen existing chronic disease. Studies have shown that chronic stress has negative effects on the gastrointestinal tract such as inflammation and disruption of the beneficial bacteria that live there.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis) |
| Lead sponsor | Nova Scotia Health Authority |
| Enrollment | 70 (estimated) |
| Start date | 2027-09-01 |
| Primary completion (est.) | 2028-02-01 |
| First posted | 2025-12-05 |
| Last updated | 2026-09-08 |
| Official title | Targeting the Brain-gut Axis in Inflammatory Bowel Diseases: Implementation and Exploration of Mechanism and Early Effectiveness of a Mindfulness-based Stress Reduction Program |
| ClinicalTrials.gov ID | NCT07266883 |
Interventions
- Mindfulness based stress reduction (Behavioral)
A mindfulness based stress reduction (MBSR) course. Participants will complete this course, which will have weekly sessions over Zoom (group format) over 8 weeks. Homework exercises will also be part of the course. - Active Control (Other)
Educational stress reduction video
Full eligibility criteria (from the record)
Inclusion Criteria: * 18 years of age or older * having a known diagnosis of IBD that is mildly to moderately active Exclusion Criteria: * Pediatric participants
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| QEII Health Sciences Centre | Halifax, Nova Scotia | Canada |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.